Bob Blasdel, PhD
Bob Blasdel, PhD
Vesale Pharma
Verified email at
Cited by
Cited by
Phage treatment of human infections
ST Abedon, SJ Kuhl, BG Blasdel, EM Kutter
Bacteriophage 1 (2), 66-85, 2011
Quality and safety requirements for sustainable phage therapy products
JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ...
Pharmaceutical research 32 (7), 2173-2179, 2015
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
R Fish, E Kutter, G Wheat, B Blasdel, M Kutateladze, S Kuhl
Journal of wound care 25 (Sup7), S27-S33, 2016
Pseudomonas predators: understanding and exploiting phage–host interactions
J De Smet, H Hendrix, BG Blasdel, K Danis-Wlodarczyk, R Lavigne
Nature Reviews Microbiology 15 (9), 517-530, 2017
Development of giant bacteriophage ϕKZ is independent of the host transcription apparatus
PJ Ceyssens, L Minakhin, A Van den Bossche, M Yakunina, E Klimuk, ...
Journal of virology 88 (18), 10501-10510, 2014
High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection
J De Smet, M Zimmermann, M Kogadeeva, PJ Ceyssens, W Vermaelen, ...
The ISME journal 10 (8), 1823-1835, 2016
A suggested new bacteriophage genus:“Viunalikevirus”
EM Adriaenssens, HW Ackermann, H Anany, B Blasdel, IF Connerton, ...
Archives of virology 157 (10), 2035-2046, 2012
Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains
C Rohde, G Resch, JP Pirnay, BG Blasdel, L Debarbieux, D Gelman, ...
Viruses 10 (4), 178, 2018
Next-Generation “-omics” Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa
A Chevallereau, BG Blasdel, J De Smet, M Monot, M Zimmermann, ...
PLoS genetics 12 (7), e1006134, 2016
Characterization of a ViI-like phage specific to Escherichia coli O157: H7
EM Kutter, K Skutt-Kakaria, B Blasdel, A El-Shibiny, A Castano, D Bryan, ...
Virology journal 8 (1), 1-14, 2011
RNA-sequencing reveals the progression of phage-host interactions between φR1-37 and Yersinia enterocolitica
K Leskinen, BG Blasdel, R Lavigne, M Skurnik
Viruses 8 (4), 111, 2016
Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials
R Fish, E Kutter, G Wheat, B Blasdel, M Kutateladze, S Kuhl
Bacteriophage Therapy, 159-170, 2018
Phage Therapy: Bacteriophages as Natural, Self-limiting Antibiotics.
E Kutter, SJ Kuhl, Z Alavidze, BG Blasdel
Textbook of Natural Medicine, Fourth edition., 945-956, 2012
Functional elucidation of antibacterial phage ORFans targeting Pseudomonas aeruginosa
J Wagemans, BG Blasdel, A Van den Bossche, B Uytterhoeven, ...
Cellular microbiology 16 (12), 1822-1835, 2014
Comparative transcriptomics analyses reveal the conservation of an ancestral infectious strategy in two bacteriophage genera
BG Blasdel, A Chevallereau, M Monot, R Lavigne, L Debarbieux
The ISME journal 11 (9), 1988-1996, 2017
Transcriptomic analysis of the Campylobacter jejuni response to T4-like phage NCTC 12673 infection
JC Sacher, A Flint, J Butcher, B Blasdel, HM Reynolds, R Lavigne, ...
Viruses 10 (6), 332, 2018
From host to phage metabolism: hot tales of phage T4’s takeover of E. coli
E Kutter, D Bryan, G Ray, E Brewster, B Blasdel, B Guttman
Viruses 10 (7), 387, 2018
Integrative omics analysis of Pseudomonas aeruginosa virus PA5oct highlights the molecular complexity of jumbo phages
C Lood, K Danis‐Wlodarczyk, BG Blasdel, HB Jang, D Vandenheuvel, ...
Environmental microbiology 22 (6), 2165-2181, 2020
Comparative transcriptomics reveals a conserved bacterial adaptive phage response (BAPR) to viral predation
BG Blasdel, PJ Ceyssens, A Chevallereau, L Debarbieux, R Lavigne
BioRxiv, 248849, 2018
Isolation of Bacteriophages.
F Van Charante, D Holtappels, BG Blasdel, BH Burrowes
Springer, Cham; Switzerland, 2019
The system can't perform the operation now. Try again later.
Articles 1–20